Article
RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
Journal of neurosurgery - 1 Apr 2017
Zhang Qian, Liu Yaping, Zhang Dong, Wang Rong, Zhang Yan, Wang Shuo, Yu Lanbing, Lu Chaoxia, Liu Fang, Zhou Jian, Zhang Xue, Zhao Jizong
Abstract excerpt
OBJECTIVE Moyamoya disease (MMD) is a rare, genetically heterogeneous cerebrovascular disease. The authors conducted a genetic study of really interesting new gene (RING) finger protein 213 ( RNF213); actin alpha 2 ( ACTA2); BRCA1/BRCA2-containing complex subunit 3 ( BRCC3); and guanylate cyclase 1, soluble, alpha 3 ( GUCY1A3) as well as a clinical phenotype analysis in Chinese MMD patients to determine whether...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.